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W15) four days prior to the onset of a rejection episode. All of the 
patients \vho displayed positive reactions underwent transplant rejec-
tion. On the other hand, rejection was never observed within six days 
of a negative reaction. 
DISCUSSION 
The results reported here have compelling implications for the im-
munodiagnosis of transplant rejection. The test may distinguish patients 
with circulating immunoreactive cells prior to clinical evidence of re-
jection. This method reflects modifications of the techniques reported 
earlier by Govaerts, by Wolf et aI, and by Quadracci et aI, as noted 
earlier (1). The advantages of the present method, which are reflected 
in its enhanced sensitivity in the detection of cellular immunity, in-
clude (a) the small number of requisite target cells, (b) the relatively 
short incubation period, (c) its simplicity and flexibility, and (d) its 
apparent dependence on antigen recognition rather than on cellular de-
struction. Further experience with the method will ascertain whether its 
immunodiagnostic efficiency warrants intensified immunosuppressive 
treatment for rejection solely on this basis and without any clinical evi-
dence of graft destruction. 
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HL-A TYPING has proved to be a poor predictor of kidney compati-
bility (1). It has been claimed that genes determining mixed lympho-
cyte culture (MLC) are apart from those of HL-A (2). Considering 
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cellular processes in the induction phase of rejection mechanism, MLC 
would seem to be a logical tool for donor selection. 
METHODS 
MLC was studied in 42 patients with kidney and 9 patients with liver 
transplantation. Kidney recipients were divided into primary related 
(19 patients), primary unrelated (14 patients) and secondary or mul-
tiple unrelated transplants (9 patients). None of the first two groups, 
but all of the last group were under immunosuppression at the time of 
MLC. Follow-up studies are for one to nirie months after transplanta-
tion, excluding no patients. Rejection was diagnosed pathologically 
and by positive findings on two consecutive days of three clinical lab-
oratory tests (blood urea nitrogen, creatinine clearance, and urine 
sodium concentration for kidney; serum bilirubin, transaminases, and 
alkaline phosphatase for liver). MLC was performed by Bach's method 
(3) with modifications. Stimulation index (SI) of MLC was defined 
by the ratio between the reaction of recipient cells to mitomycin-C-
treated donor cells and that to mitomycin-C-treated recipient cells. A 
Sllower than 10 was considered compatible; those with SI higher than 
10 were designated incompatible. 
RESUL TS AND CONCLUSIONS 
The results (Table 1) indicated a positive although imperfect corre-
lation between one-way MLC and the clinical course after primary kid-
ney transplantation, either related or unrelated. A good MLC match 
was much more common than good HL-A matching. Similar findings 
have been reported by other authors (4,5), although they have used 
two-way MLC. Except for the double haplotype identical sibling cases, 
there was no correlation between HL-A and MLC. Even among these 
sibling cases there were two patients who rejected kidneys despite an 
identical HL-A and MLC. This finding and the report of Seigler and 
associates (6) suggests the possibility that minor incompatibilities may 
have been responsible. Immunosuppressive therapy apparently affected 
the MLC results, and the potential ability of the recipient to reject the 
graft was not adequately expressed by the MLC (Table 1). With 
liver transplantation, there has not yet been a correlation between out-
come and MLC. 
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IN ASMUCH AS THE KID!\EY failure of the hepatorenal syndrome (1) is 
believed to be secondary to hepatic dysfunction, replacement of the 
diseased liver should improve renal function. This objective was real-
ized in three patients with the hepatorenal syndrome treated by ortho-
topic liver transplantation. 
CASE MATERIAL 
The patients, who were 34, 42, and 44 yr old, suffered from cirrhosis. 
They had massive ascites and edema and two of them were in stage III 
or IV coma. All had had normal renal function documented within a 
few weeks of transplantation, but progressive renal failure had then 
supervened \vith azotemia and oliguria. Two patients had a preopera-
tive urine sodium concentration of less than 1 mEq/liter, while in case 
3 it was 40 mEq/liter. The degree of combined renal and hepatic fail-
ure can be seen in Table 1. 
RESULTS 
Hepatic function in all three patients steadily improved after liver 
replacement (Table 1), but the course of recovery of kidney function 
varied. In cases 1 and 3 the characteristic urine findings, including 
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